Skip to main content
logo
Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China flag China · Delayed Price · Currency is CNY
81.45
+0.74 (0.92%)
Apr 29, 2026, 4:00 PM EDT

SHE:301075 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Market Capitalization
6,4314,7111,4192,1342,5873,113
Market Cap Growth
256.46%232.05%-33.50%-17.53%-16.89%-
Enterprise Value
6,6455,0251,3031,8512,1162,503
Last Close Price
81.4559.6717.9726.4932.1237.76
PE Ratio
---113.18126.1945.44
PS Ratio
41.7130.565.906.386.455.88
PB Ratio
10.317.561.882.603.433.95
P/TBV Ratio
13.429.832.452.913.544.01
P/FCF Ratio
-----72.72
P/OCF Ratio
---171.882296.4164.65
EV/Sales Ratio
43.1032.595.425.545.284.72
EV/EBITDA Ratio
---117.47128.6832.90
EV/EBIT Ratio
----1167.4140.12
EV/FCF Ratio
-45.01----58.47
Debt / Equity Ratio
0.430.430.720.220.130.03
Debt / EBITDA Ratio
---11.025.760.27
Debt / FCF Ratio
-----0.48
Net Debt / Equity Ratio
0.270.270.18-0.37-0.54-0.75
Net Debt / EBITDA Ratio
-3.64-3.64-2.20-19.21-24.60-7.76
Net Debt / FCF Ratio
-1.12-1.12-1.2526.8512.80-13.79
Asset Turnover
0.110.110.190.340.460.87
Inventory Turnover
2.192.193.773.224.354.90
Quick Ratio
0.480.481.044.494.1911.36
Current Ratio
0.740.741.245.024.4811.61
Return on Equity (ROE)
-19.23%-19.23%-10.80%2.17%2.41%12.80%
Return on Assets (ROA)
-4.19%-4.19%-4.21%-0.16%0.13%6.38%
Return on Invested Capital (ROIC)
-11.08%-11.27%-12.48%-0.46%0.59%30.35%
Return on Capital Employed (ROCE)
-11.20%-11.20%-8.60%-0.30%0.20%7.90%
Earnings Yield
-1.59%-2.17%-4.42%0.88%0.79%2.20%
FCF Yield
-2.30%-3.13%-7.62%-0.53%-1.22%1.38%
Dividend Yield
---0.47%-1.65%
Payout Ratio
---17.26%247.95%1.68%
Buyback Yield / Dilution
-0.01%0.16%-0.99%0.39%-20.86%-8.52%
Total Shareholder Return
-0.01%0.16%-0.99%0.86%-20.86%-6.87%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.